stockrow
Monday 9 November 2026
Export ADRX’s income statement to Excel — free account
ADARx Pharmaceuticals, Inc.
ADRX
13.23
0.06
−0.45%
Follow ADRX
Alert me
ADARx Pharmaceuticals, Inc. (ADRX) Return on invested capital
Return on invested capital, annual
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| PGEN Precigen, Inc. compare | 15.9% |
| OCUL Ocular Therapeutix, Inc. compare | 0.00% |
| QURE uniQure N.V. compare | 0.00% |
| AAPG Ascentage Pharma Group International - Unsponsored ADR compare | 0.00% |
| TYRA Tyra Biosciences, Inc. compare | 0.00% |
| NBTX Nanobiotix S.A. - Sponsored ADR compare | 0.00% |
| IMCR Immunocore Holdings PLC Sponsored ADR compare | 0.00% |
| NUVB Nuvation Bio Inc. compare | 0.00% |
| ADRX ADARx Pharmaceuticals, Inc. | — |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)